Literature DB >> 15450801

A 384-well cell-based phospho-ERK assay for dopamine D2 and D3 receptors.

Stephen K-F Wong1.   

Abstract

Phosphorylation of extracellular signal-regulated kinase (ERK) is linked to activation of many cell surface receptors and kinases. However, phosphorylated ERK has not been used as a biochemical marker to monitor pharmacology of these biomolecules, largely because commonly used methods to detect the phosphoprotein are not quantitative and do not have sufficient throughput. In this article, a high-throughput, 384-well, cell-based functional assay to quantify dopamine agonist-induced ERK phosphorylation in D2- and D3-overexpressed cell lines is described. The assay uses infrared-labeled secondary antibodies to detect phospho-ERK, and the signals in the wells of the microtiter plate are quantified by a LI-COR infrared scanner. V(max), EC(50), and functional K(i) values of various D2 and D3 agonists and antagonists determined in this assay are similar to those in the literature. The assay is nonradioactive, is quantitative, and has a good signal-to-noise ratio. In addition, the signal is stable. This assay can be used to monitor the activities of many G protein-coupled receptors and other signaling biomolecules that are linked to phosphorylation of ERK. The methodology can potentially be used to detect the change in level of any cellular protein in which highly selective antibodies are available.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450801     DOI: 10.1016/j.ab.2004.05.011

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  13 in total

1.  Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists.

Authors:  Amey Dhopeshwarkar; Natalia Murataeva; Alex Makriyannis; Alex Straiker; Ken Mackie
Journal:  J Pharmacol Exp Ther       Date:  2016-12-07       Impact factor: 4.030

2.  Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds.

Authors:  Robert R Luedtke; Yogesh Mishra; Qi Wang; Suzy A Griffin; Cathy Bell-Horner; Michelle Taylor; Suwanna Vangveravong; Glenn H Dillon; Ren-Qi Huang; David E Reichert; Robert H Mach
Journal:  ACS Chem Neurosci       Date:  2012-10-12       Impact factor: 4.418

3.  Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs GLUT4 vesicle trafficking and glucose transport.

Authors:  Alicia M McCarthy; Kristen O Spisak; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Am J Physiol Cell Physiol       Date:  2006-06-14       Impact factor: 4.249

4.  Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism.

Authors:  Andrew B Strawbridge; Jeffrey S Elmendorf
Journal:  J Cell Biochem       Date:  2006-03-01       Impact factor: 4.429

5.  Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.

Authors:  James Bennett; Jeffrey Burns; Paul Welch; Rebecca Bothwell
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

6.  Phosphatidylinositol 4,5-bisphosphate reverses endothelin-1-induced insulin resistance via an actin-dependent mechanism.

Authors:  Andrew B Strawbridge; Jeffrey S Elmendorf
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

7.  Traumatic brain injury in young rats leads to progressive behavioral deficits coincident with altered tissue properties in adulthood.

Authors:  David O Ajao; Viorela Pop; Joel E Kamper; Arash Adami; Emil Rudobeck; Lei Huang; Roman Vlkolinsky; Richard E Hartman; Stephen Ashwal; André Obenaus; Jérôme Badaut
Journal:  J Neurotrauma       Date:  2012-07-20       Impact factor: 5.269

8.  A reliable cell-based assay for testing unclassified TSC2 gene variants.

Authors:  Ricardo Coevoets; Sermin Arican; Marianne Hoogeveen-Westerveld; Erik Simons; Ans van den Ouweland; Dicky Halley; Mark Nellist
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

9.  Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance.

Authors:  Emily M Horvath; Lixuan Tackett; Alicia M McCarthy; Priya Raman; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Mol Endocrinol       Date:  2007-12-28

10.  Pharmacology of alpha7 nicotinic acetylcholine receptor mediated extracellular signal-regulated kinase signalling in PC12 cells.

Authors:  R El Kouhen; M Hu; D J Anderson; J Li; M Gopalakrishnan
Journal:  Br J Pharmacol       Date:  2009-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.